Bone Turnover in Prolonged Critical Illness: Effect of Vitamin D

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4623-4632

  Van Den Berghe, Greet ^a   Van Roosbroeck, David ^a   Vanhove, Philippe ^a   Wouters, Pieter J ^a   De Pourcq, Lutgart ^a   Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM ION; CERNEVIT; COLECALCIFEROL; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; INTERLEUKIN 1; INTERLEUKIN 6 RECEPTOR; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PYRIDINOLINE; SOLUVIT; TUMOR NECROSIS FACTOR ALPHA; VITALIPID INFANT; VITAMIN D; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; BONE TURNOVER; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MALE; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ACUTE DISEASE; ADULT; AGED; BONE RESORPTION; C-REACTIVE PROTEIN; CALCITRIOL; CALCIUM; CREATININE; CRITICAL ILLNESS; FEMALE; HUMANS; HYDROXYLATION; INTENSIVE CARE; INTERLEUKIN-6; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; PARATHYROID HORMONE; PROSPECTIVE STUDIES; UREA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0242320434     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030358     Document Type: Article

References (54)

1. Van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD 2001 Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab 86:3217-3226
2. Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY, Bouillon R 1999 Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 84:1311-1323
3. Van den Berghe G, de Zegher F, Bouillon R 1998 Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83:1827-1834
4. Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R 2002 The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 56:655-669
5. Nierman DM, Mechanick JI 1998 Bone hyperresorption is prevalent in chronically critically ill patients. Chest 114:1122-1128
6. Nierman DM, Mechanick JI 2000 Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. Chest 118:761-766
7. Smith LM, Cuthbertson B, Harvie J, Webster N, Robins S, Ralston SH 2002 Increased bone resorption in the critically ill: association with sepsis and increased nitric oxide production. Crit Care Med 30:837-840
8. Lips P 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501
9. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride 1997 In: Food and Nutrition Board, ed. Washington: National Academy Press; 1-30
10. Vieth R 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 69:842-856
11. Heaney RP, Waever CM 2003 Calcium and vitamin D. Endocrinol Metab Clin North Am 32:181-194
12. Dawson-Hughes B 1998 Vitamin D and calcium: recommended intake for bone health. Osteoporos Int 8:S30-S34
13. The A. S. P. E. N. Board of Directors, the Clinical Guidelines Task Force 2002 Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 26:1SA-138SA
14. Shike M, Harrison JE, Sturtridge WC, Tam CS, Bobechko PE, Jones G, Murray TM, Jeejeebhoy KN 1980 Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med 92:343-350
15. Shike M, Sturtridge WC, Tam CS, Harrison JE, Jones G, Murray TM, Husdan H, Whitwell J, Wilson DR, Jeejeebhoy KN 1981 A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease. Ann Intern Med 95:560-568
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE 1985 APACHE II: a severity of disease classification system. Crit Care Med 13:818-829
17. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lau wers P, Bouillon R 2001 Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367
18. Bouillon R, Coopmans W, Degroote DE, Radoux D, Eliard PH 1990 Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 36:271-276
19. Fournier A, Solal ME, Oprisiu R, Mazouz H, Morinire P, Choukroun G, Bouillon R 2001 Optimal range of plasma concentration of true 1-84 parathyroid hormone in patients on maintenance dialysis. J Clin Endocrinol Metab 86:1840-1842
20. Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P 1981 Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 67:589-596
21. Bouillon R, Vanderschueren D, Van Herck E, Nielsen HK, Bex M, Heyns W, Van Baelen H 1992 Homologous radioimmunoassay of human osteocalcin. Clin Chem 38:2055-2060
22. Boonen S, Vanderschueren D, Cheng XG, Verbeke G, Dequeker J, Geusens P, Broos P, Bouillon R 1997 Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminos. J Bone Miner Res 12:2119-2126
23. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ 1992 Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642
24. Bouillon R, Auwerx JH, Lissens WD, Pelemans WK 1987 Vitamin-D status in the elderly - seasonal substrate deficiency causes 1,25- dihydroxycholecalciferol deficiency. Am J Clin Nutr 45:755-763
25. Dahl B, Schiodt FV, Nielsen M, Kiaer T, Williams JG, Ott P 1999 Admission level of Gc-globulin predicts outcome after multiple trauma. Injury 30:275-281
26. Van Baelen H, Bouillon R, De Moor P 1980 Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem 255:2270-2272
27. Goldschmidt-Clermont PJ, Van Baelen H, Bouillon R, Shook TE, Williams MH, Nel AE, Galbraith RM 1988 Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit. J Clin Invest 81:1519-1527
28. Seibel MJ, Eastell R, Gundberg CM, Hannon R, Pols HAP 2002 Biochemical markers of bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. Vol 2. San Diego: Academic Press; 1543-1571
29. Robins SP 1998 Biochemical markers of bone turnover. In: Arnett TR, Henderson B, eds. Methods in bone biology. London: Chapman, Hall; 229-250
30. Eastell R, Colwell A, Hampton L, Reeve J 1997 Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res 12:59-65
31. Nylen ES, Alarifi AA 2001 Humoral markers of severity and prognosis of critical illness. Best Pract Res Clin Endocrinol Metab 15:553-573
32. De la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR, Roodman GD 1995 Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 95:2846-2852
33. Reddy SV, Takahashi S, Dallas M, Williams RE, Neckers L, Roodman GD 1994 Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell rumors of bone. J Bone Miner Res 9:753-757
34. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
35. Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, Risteli L, Lee YC, Feizi T, Langen H, Nussenzweig MC 2002 Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898-1901
36. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196
37. Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD 2002 Osteoclasts formed by normal human bone marrow cells transduced with the measles virus nucleocapsid gene express a pagetic phenotype. J Clin Invest 105:607-614
38. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
39. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T 1993 Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924-11928
40. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL 2000 TNFá induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488
41. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS 1990 Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430
42. Lynch MP, Capparelli C, Stein JL, Stein GS, Lian JB 1998 Apoptosis during bone-like tissue development in vitro. J Cell Biochem 68:31-49
43. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian JP 1992 Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 74:481-486
44. Harvey RD, McHardy KC, Reid IW, Paterson F, Bewsher PD, Duncan A, Robins SP 1991 Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab 72:1189-1194
45. Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK 2001 Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab 86:2020-2026
46. Fukuoka H, Nishimura Y, Haruna M, Suzuki Y, Oyama K, Igawa S, Sekiguchi C, Murai T, Shigematsu T, Sudoh M, Akimura H, Gunji A 1997 Effect of bed rest immobilization on metabolic turnover of bone and bone mineral density. J Gravit Physiol 4:S75-S81
47. Lips P, van Ginkel FC, Netelenbos JC, Wiersinga A, van der Vijgh WJ 1990 Lower mobility and markers of bone resorption in the elderly. Bone Miner 9:49-57
48. Carmeliet G, Vico L, Bouillon R 2001 Space flight: a challenge for normal bone homeostasis. Crit Rev Eukaryot Gene Expr 11:131-144
49. Zerwekh JE, Ruml LA, Gottschalk F, Pak CY 1998 The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 13:1594-1601
50. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS 2000 Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood 96:3188-3194
51. Mathieu C, Adorini L 2002 The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8:174-179
52. Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257
53. Meehan TF, DeLuca HF 2002 The vitamin D receptor is necessary for 1á, 25-dihydroxyvitaminD3 to suppress experimental autoimmune encephalitis in mice. Arch Biochem Biophys 408:200-2004
54. Weekers F, Van Herck E, Coopmans W, Michalaki M, Bowers CY, Veldhuis JD, Van den Berghe G 2002 A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 143:764-774